Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Jean-Marie Stephan"'
Autor:
John H. Farley, William E. Brady, David O'Malley, Keiichi Fujiwara, Kan Yonemori, Albert Bonebrake, Angeles Alvarez Secord, Jean-Marie Stephan, Joan L. Walker, Joo-Hyun Nam, Michael J. Birrer, David M. Gershenson
Publikováno v:
Gynecologic oncology. 167(3)
The primary objective of the study was to estimate the 12-month progression-free survival (PFS) for carboplatin/paclitaxel + temsirolimus in women with newly diagnosed clear cell ovarian cancer (CCOC), compared to historical controls in this patient
Publikováno v:
Journal of Gynecologic Surgery. 37:197-199
Autor:
Jean-Marie STEPHAN
Publikováno v:
Journal of Physics A: Mathematical and Theoretical. 55:204003
We study the time evolution of the spin-1/2 XXZ chain initialized in a domain wall state, where all spins to the left of the origin are up, all spins to its right are down. The focus is on exact formulae, which hold for arbitrary finite (real or imag
Autor:
Larissa Mattei, Andras Ladanyi, Ivana Barouhas, Summer B. Dewdney, Amina Ahmed, Qudsia Ladani, Jean-Marie Stephan
Publikováno v:
Gynecologic Oncology. 162:S146-S147
Objectives: The aim of this study was to assess for an association between the sequence of surgical and systemic treatment and overall survival in patients with Stage IV endometrial cancer, as well as to identify prognostic factors for mortality. Met
Publikováno v:
Clinical obstetrics and gynecology. 63(1)
Minimally invasive surgery has become a standard in the surgical treatment for many women with gynecologic cancers. Within the scope of minimally invasive surgery, several techniques exist. Here, we provide an overview of the challenging and controve
Autor:
Jean-Marie Stephan, Ramez N. Eskander, Robert E. Bristow, Chad A. Hamilton, Frederick R. Ueland, Krishnansu S. Tewari, Stephen C. Rubin, Keiichi Fujiwara, Gretchen E. Glaser, James Kauderer, David M. O'Malley, Robert S. Mannel, Warner K. Huh, Robert A. Burger
Publikováno v:
Gynecol Oncol
PURPOSE: We sought to determine the level of concordance among surgeons’ assessment of residual disease (RD) and pre-treatment computed tomography (CT) findings among women who underwent optimal surgical cytoreduction for advanced stage ovarian can
Autor:
Peter G. Rose, David G. Mutch, Peter A. Argenta, Michael A. Bookman, Robert S. Mannel, Michael J. Birrer, Jean-Marie Stephan, Larry J. Copeland, John H. Farley, Franco M. Muggia, William E. Brady, Frederick B. Stehman, Deborah K. Armstrong, Krishnansu S. Tewari, Gini F. Fleming, Angeles Alvarez Secord, Kate E. Oliver, Robert A. Burger, David M. Gershenson
Publikováno v:
Gynecologic Oncology. 147:243-249
We examined disparities in prognosis between patients with ovarian clear cell carcinoma (OCCC) and serous epithelial ovarian cancer (SOC).We reviewed data from FIGO stage I-IV epithelial ovarian cancer patients who participated in 12 prospective rand
Autor:
Kristina W. Thiel, Virginia L. Filiaci, Megan I. Samuelson, Gini F. Fleming, Eric J. Devor, Yuping Zhang, Megan E McDonald, Henry D. Reyes, Saketh R. Guntupalli, Parviz Hanjani, Krishnansu S. Tewari, Nilsa C. Ramirez, Floor J. Backes, Kimberly K. Leslie, Jeffrey C. Miecznikowski, Jesus Gonzalez-Bosquet, Jean-Marie Stephan, Michael J. Birrer
Publikováno v:
Reyes, HD; Miecznikowski, J; Gonzalez-Bosquet, J; Devor, EJ; Zhang, Y; Thiel, KW; et al.(2017). High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study. GYNECOLOGIC ONCOLOGY, 146(2), 247-253. doi: 10.1016/j.ygyno.2017.05.017. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/5hp2v0d7
Objective Gynecologic Oncology Group (GOG) 177 demonstrated that addition of paclitaxel to a backbone of adriamycin/cisplatin improves overall survival (OS) and progression-free survival (PFS) for patients with advanced or recurrent endometrial cance
Publikováno v:
Proceedings in Obstetrics and Gynecology. 8:1-2
To assess clinical characteristics and treatment modalities in patients with small cell carcinoma of the cervix and the effect this has on overall (OS) and recurrence free survival (RFS).
Autor:
Xiangbing Meng, Henry D. Reyes, Matthew Carlson, Shujie Yang, Kimberly K. Leslie, Kristina W. Thiel, Jean-Marie Stephan
Publikováno v:
Molecular Diagnosis & Therapy. 18:137-151
The primary gynecologic cancers include cancers of the endometrium, ovary, and cervix. Worldwide, cervical cancer is the most common gynecologic cancer, whereas endometrial cancer is the most common in the US. Ovarian cancer is the fifth most deadly